Huffington Post features CN Bio CEO: Women in Innovation: Developing ‘Organs-on-Chips’ Interview clip: “My background as a chemist means that I like precision. However, drug development is not nearly as logical as we’d like. Profound uncertainty about the likely success of drug programs can persist into late stage clinical trials – by which time millions… Read more »
Discovery Channel features CN Bio’s human-organ-on-a-chip platforms “Innovations” on the Discovery Channel has reported on CN Bio Innovations’ technology which allows drug discovery scientists to understand with greater precision than ever before whether a new drug candidate is likely to be safe and effective. “Innovations” is hosted by Ed Begley Jr, and the CN Bio… Read more »
CN Bio Innovations features in Al Jazeera documentary “The Cure”.
CN Bio’s COO, Dr Emma Sceats, interviewed for BBC Impact.
Towards a body on a chip.
Drug Testing, Now without the Chimp
Drug Disruption: The ‘Liver-on-a-chip’
CN Bio’s flagship liver on a chip platform, LiverChip, has been featured both in a technology snapshot in the March 23rd issue of Businessweek and in a separate article published on the Bloomberg website.
CN Bio’s LiverChip helps battle Hepatitis B
- Press releases
- 5 April 2017
- CN Bio Innovations announces license of worldwide rights to Hepatitis B programme from Bristol-Myers Squibb
- Media Coverage
- 3 February 2017
- Huffington Post features CN Bio